Mcap of five of top 10 most valued firms decline by Rs 62,586 cr; TCS, Infosys biggest laggardsMcap of five of top 10 most valued firms decline by Rs 62,586 cr; TCS, Infosys biggest laggards

The combined market valuation of five of the top 10 most valued firms declined by Rs 62,586.88 crore last week, with IT majors Tata Consultancy Services (TCS) and Infosys taking the biggest hit, amid an overall bearish trends in equities. Last week, the BSE benchmark fell 180.74 points or 0.27 per cent, and the Nifty […]

SAT rejects appeals against Sebi’s interim order in Eros fund diversion caseSAT rejects appeals against Sebi’s interim order in Eros fund diversion case

The Securities Appellate Tribunal (SAT) on Tuesday rejected appeals of Eros International Media Ltd, its Managing Director Sunil Arjan Lulla and Chief Executive Officer Pradeep Kumar Dwivedi that challenged Sebi‘s order restraining them from the capital market in a fund diversion case. “We do not find any reason to interfere with the impugned order at […]

Sebi seeks to calm FPI fears through relaxed guidelines for NRIs, OCIsSebi seeks to calm FPI fears through relaxed guidelines for NRIs, OCIs

In a consultation paper issued recently, the Securities and Exchange Board of India (Sebi) has proposed to allow higher investments from Non-Resident Indians (NRIs) and Overseas Citizens of India (OCIs) through Foreign Portfolio Investors (FPIs) operating out of International Financial Services Centers (IFSC). Market experts believe that Sebi’s proposal comes at a time when it […]

Mid-caps, small-caps likely to lose steam in second halfMid-caps, small-caps likely to lose steam in second half

After the exuberance over mid-caps and small-caps in the first half of the financial year, markets experts are expecting large-caps to take the lead in the second half of the financial year. Experts believe that investors will prefer safe havens because of the uncertainty around various key events. These include elections in India, potential rate […]

Nifty witnessing range bound activity after sharp bounce back; Federal Bank, Tata Steel among stocks to buyNifty witnessing range bound activity after sharp bounce back; Federal Bank, Tata Steel among stocks to buy

By Shrikant Chouhan On Tuesday, the benchmark indices witnessed range bound activity, Nifty ended 20 points higher while the Sensex was up by 62 points. Among sectors, PSU Banks continued positive momentum for the second day in a row whereas media and selective financial stocks registered intraday profit booking at higher levels. Technically, after a […]

Stocks To Watch: ACC, Nykaa, HDFC AMC, TVS Motor, PNB, Adani Enterprises, LTIMindtree, NTPC, Bata IndiaStocks To Watch: ACC, Nykaa, HDFC AMC, TVS Motor, PNB, Adani Enterprises, LTIMindtree, NTPC, Bata India

Stocks in focus: The GIFT Nifty was 0.34% lower during Friday’s early trading session at 19,317, indicating an opening in the red for domestic indices NSE Nifty 50 and BSE Sensex. On Thursday, domestic benchmarks NSE Nifty 50 and BSE Sensex ended in negative territory. The Sensex closed down by 0.6% at 65,151.02, while the […]

EMS IPO opens for subscription, GMP up 56%; should you subscribe to the issue?EMS IPO opens for subscription, GMP up 56%; should you subscribe to the issue?

EMS IPO: EMS IPO opens for public subscription on Friday, 8 September, and will close on Tuesday, 12 September. The bidding for anchor investors concluded on Thursday, wherein the company collected Rs 95.37 crore. The price band for its public issue at Rs 200-211 per equity share of face value Rs 10 each. At the […]

Rupee rises 38 paise to 82.75 against US dollar in early tradeRupee rises 38 paise to 82.75 against US dollar in early trade

The rupee appreciated by 38 paise to 82.75 against the US dollar in early trade on Friday, as the inclusion of India in the JPMorgan bond index boosted investor sentiment. Forex traders said the decision of JPMorgan Chase & Co to include Indian government bonds in its benchmark emerging-market index, is expected to have far-reaching […]

BDR Pharma launches oral solution for prostate cancer in IndiaBDR Pharma launches oral solution for prostate cancer in India

BDR Pharmaceuticals on Tuesday launched an oral solution in 32mg/mL designed for the management of prostate cancer. According to a press statement, BDENZA will be available at Rs. 27,000 for 150mL. “This innovative formulation marks a significant step forward in providing an effective dosage form, with lesser side effects in comparison to existing oral dosage […]